Birch Grove Capital LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 23 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Birch Grove Capital LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$23,462,000
+48.9%
25,985,000
+33.3%
12.71%
-2.7%
Q2 2020$15,758,000
+21.7%
19,500,000
+18.2%
13.06%
-29.5%
Q1 2020$12,949,000
+16.1%
16,500,000
+22.2%
18.53%
+33.9%
Q4 2019$11,158,000
-0.7%
13,500,0000.0%13.83%
+65.7%
Q3 2019$11,239,000
+3.1%
13,500,0000.0%8.35%
+0.6%
Q2 2019$10,897,00013,500,0008.30%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Context Capital Management, LLC 8,800,000$9,006,0007.74%
STEELHEAD PARTNERS LLC 49,265,000$50,805,0004.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,025,000$39,317,0002.35%
CAMDEN ASSET MANAGEMENT L P /CA 25,875,000$26,415,0000.87%
Opera Trading Capital 4,500,000$4,620,0000.74%
Telemetry Investments, L.L.C. 1,500,000$1,531,0000.58%
SSI INVESTMENT MANAGEMENT LLC 5,500,000$5,615,0000.46%
AQR Arbitrage LLC 32,975,000$33,746,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 31,050,000$32,023,0000.41%
City Financial Investment Co Ltd 7,500,000$7,862,0000.40%
View complete list of AMAG PHARMACEUTICALS INC shareholders